Concepedia

Carla Calagua

CC

12

Publications

829

Citations

11

H-Index

2017

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Dana-Farber Cancer Institute

University of California, Los Angeles

University of Washington

Carla Calagua is an author at Beth Israel Deaconess Medical Center specializing in medicine, urology, and tumor biology.

ORCID

Top concepts

Publications per year

2017–2022

12

Publications

12

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Katherine L. Morel, Anjali V. Sheahan, Deborah L. Burkhart et al. · Nature Cancer · 2021 · 228 citations · Full text

, , +6

Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone

Rana R. McKay, Huihui Ye, Wanling Xie et al. · Journal of Clinical Oncology · 2019 · 156 citations · Full text

Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide

Carla Calagua, Joshua W. Russo, Yue Sun et al. · Clinical Cancer Research · 2017 · 88 citations

Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations

Adam G. Sowalsky, Huihui Ye, Manoj Bhasin et al. · Cancer Research · 2018 · 72 citations

Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer

Rana R. McKay, Wanling Xie, Huihui Ye et al. · The Journal of Urology · 2021 · 70 citations · Full text

Rows per page

1–5 of 12